Ruscitti, P. et al. Recent advances and evolving concepts in Still’s disease. Nat. Rev. Rheumatol. 20, 116–132 (2024).

Article  PubMed  Google Scholar 

De Matteis, A. et al. Systemic juvenile idiopathic arthritis and adult-onset Still’s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still’s disease. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-225853 (2024).

Article  PubMed  Google Scholar 

Fautrel, B. et al. EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-225851 (2024).

Article  PubMed  Google Scholar 

Pardeo, M. et al. Early treatment and Il1Rn single-nucleotide polymorphisms affect response to Anakinra in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 73, 1053–6101 (2021).

Article  CAS  PubMed  Google Scholar 

Shakoory, B. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Arthritis Rheumatol. 75, 1714–1732 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vitale, A. et al. Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’qsease registry. RMD Open 9, e003578 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Bindoli, S. et al. Adult-onset Still’s disease (AOSD): advances in understanding pathophysiology, genetics and emerging treatment options. Drugs 84, 257–274 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song, Z. et al. Ruxolitinib as a salvage therapy in adult-onset macrophage activation syndrome: insights from eight cases. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2024-226433 (2024).

Article  PubMed  Google Scholar 

Shen, Y. et al. Advancing personalised precision treatment for Still’s disease based on molecular characteristics and disease progression. Lancet Rheumatol. https://doi.org/10.1016/S2665-9913(24)00225-X (2024).

Article  PubMed  Google Scholar